pentobarbital will lower the extent or outcome of nateglinide by impacting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Keep an eye on.
pentobarbital will raise the amount or impact of clopidogrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lower the level or result of erlotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
buprenorphine subdermal implant and pentobarbital both equally enhance sedation. Prevent or Use Alternate Drug. Restrict use to individuals for whom choice treatment method selections are inadequate
pentobarbital will lessen the level or impact of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Check Carefully (2)pentobarbital will decrease the extent or result of oliceridine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. If coadministration having a CYP3A4 inducer is necessary, consider expanding oliceridine dose until finally secure drug results are reached; observe for signs of opioid withdrawal.
Watch Closely (1)pentobarbital will lessen the extent or effect of hydrocodone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Warning when discontinuing CYP3A4 inducers that are coadministered with hydrocodone; plasma concentrations of hydrocodone could enhance and may lead to likely fatal respiratory depressionSerious - Use Option (1)hydrocodone, pentobarbital.
Contraindicated (one)pentobarbital will decrease the extent or effect of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or result of verapamil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will decrease the extent or result of oxybutynin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
pentobarbital will lower the level or influence of imatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.
pentobarbital will lower the level or impact of efavirenz by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.
pentobarbital will reduce the extent or outcome of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use check here Warning/Observe.
pentobarbital will lower the level or outcome of diazepam buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Sturdy or reasonable CYP3A4 inducers could boost price of diazepam elimination; as a result, efficacy of diazepam could possibly be lowered.